Ming Zhao
Academic / Other · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | Ablation Plus Tislelizumab Versus Ablation Alone for Intrahepatic Recurrent Early Stage HCC Recurrent Hepatocellular Carcinoma | Phase 2 | 2020-12-21 |
| Completed | TACE+RFA Versus TACE Alone for Intermediate-stage Hepatocellular Carcinoma Hepatocellular Carcinoma, Chemoembolization, Therapeutic, Ablation Techniques, RFA | Phase 3 | 2015-05-01 |
| Unknown | Combine TACE and RFA Versus TACE Alone for HCC With PVTT Hepatocellular Carcinoma | Phase 3 | 2014-10-01 |
| Approved For Marketing | HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC Hepatocellular Carcinoma, Injury; Blood Vessel, Hepatic, Artery | — | — |